137 results
8-K
EX-99.1
SCPX
Scorpius Holdings Inc.
15 May 23
NightHawk Biosciences Provides Q1 2023 Business Update
4:16pm
the body and the ensuing tissue damage that leads to death. ANTHIM is supplied as single-dose vials for IV infusion.
Indications and Usage
ANTHIM
8-K
EX-99.1
zkrz6c64fpagnc qr
31 Mar 23
NightHawk Biosciences Provides 2022 Year End Business Update
4:05pm
8-K
EX-3.2
zz79 axyyuqvucj41e
3 May 22
Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open Today
7:15am
8-K
EX-10.1
e5f7x
20 Apr 22
Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics
8:06am
8-K
EX-99.1
k6wfb
20 Apr 22
Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics
8:06am
8-K
EX-99.1
a69oh50ty0kz
12 Jan 22
Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110
8:05am
8-K
unh9tu94
12 Jan 22
Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110
8:05am
8-K
EX-99.1
lacqahmmn r2y0cg0j
5 Jan 22
Regulation FD Disclosure
6:03am
8-K
EX-10.2
tbeyo8qr3s98x6d1ph
3 Jan 22
Departure of Directors or Certain Officers
5:16pm